Attached files

file filename
EX-3.2 - EXHIBIT 3.2 - AETNA INC /PA/exhibit3_2.htm
EX-3.1 - EXHIBIT 3.1 - AETNA INC /PA/exhibit3_1.htm
EX-99.1 - EXHIBIT 99.1 - AETNA INC /PA/exhibit99_1.htm


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):
June 4, 2014 (May 30, 2014)

 
Aetna Inc.
(Exact name of registrant as specified in its charter)


Pennsylvania
1-16095
23-2229683
(State or other jurisdiction of
(Commission
(IRS Employer
incorporation)
File Number)
Identification No.)
 
 
 
151 Farmington Avenue, Hartford, CT
06156
(Address of principal executive offices)
(Zip Code)
 
 
Registrant's telephone number, including area code:
(860) 273-0123
 
 
Former name or former address, if changed since last report:
N/A
 
 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))






Section 5 - Corporate Governance and Management

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On May 30, 2014, the shareholders of Aetna Inc. ("Aetna" or the "Company") approved an amendment to the Amended Aetna Inc. 2010 Stock Incentive Plan to increase the number of shares authorized to be issued under such Plan. The Amended Aetna Inc. 2010 Stock Incentive Plan, as amended May 30, 2014, is filed as Exhibit 99.1 to this Current Report and is incorporated herein by reference.

Item 5.03
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

On May 30, 2014, the shareholders of Aetna approved (a) a proposal to amend Article 11 of the Company’s Amended and Restated Articles of Incorporation (the "Articles of Incorporation") to eliminate the supermajority voting provisions contained in the Articles of Incorporation and (b) a proposal to amend Article 8(a) of the Articles of Incorporation to provide holders of at least twenty-five percent of the voting power of all outstanding shares the right to call a special meeting of shareholders, and the Company effected those amendments. The proposals for each of those amendments were disclosed in the Company’s definitive proxy statement that was filed with the Securities and Exchange Commission on April 18, 2014 (the Company’s "2014 Proxy Statement"). A restatement of the Articles of Incorporation which includes the amendments referred to above but no other changes to the Articles of Incorporation, was effected on May 30, 2014, and is filed as Exhibit 3.1 hereto and incorporated herein by reference.

On May 30, 2014, the shareholders of Aetna approved a proposal to amend Section 5.02 of the Company’s Amended and Restated By-Laws (the "By-Laws") to eliminate the supermajority voting provisions contained in the By-Laws. Also on May 30, 2014, following the effectiveness of the amendment to Article 8(a) of the Articles of Incorporation described above, the Aetna Board of Directors (the "Board") amended Sections 1.03 and 1.04 of the By-Laws to address procedural issues in connection with the exercise of the shareholders’ right to call a special meeting of shareholders. The proposal for the amendment of Section 5.02 of the By-Laws and the text of the amendments to Sections 1.03 and 1.04 of the By-Laws were disclosed in the Company’s 2014 Proxy Statement. In addition, on May 30, 2014, the Board amended Section 4.01 of the By-Laws to eliminate the second sentence of such Section 4.01 (regarding appointment of certain officers), which was determined to be unnecessary. A copy of the By-Laws as amended is filed as Exhibit 3.2 hereto and incorporated herein by reference.

Item 5.07
Submission of Matters to a Vote of Security Holders.

Aetna's Annual Meeting of Shareholders was held on May 30, 2014. Shareholders voted on the matters set forth below.

1. Election of Director nominees. Each of the nominees listed below was elected as a Director of Aetna until the next Annual Meeting and until their successors are duly elected and qualified based on the following votes:
Nominee
Votes For

Votes Against

Abstentions

Broker Non-Votes

Fernando Aguirre
288,529,594

1,725,717

1,403,707

23,605,123

Mark T. Bertolini
279,197,630

10,072,921

2,388,467

23,605,123

Frank M. Clark
289,073,775

1,152,912

1,432,331

23,605,123

Betsy Z. Cohen
282,261,852

8,024,602

1,372,564

23,605,123

Molly J. Coye, M.D.
262,667,332

27,632,405

1,359,281

23,605,123

Roger N. Farah
286,797,907

3,333,658

1,527,453

23,605,123

Barbara Hackman Franklin
282,498,408

7,817,531

1,343,079

23,605,123

Jeffrey E. Garten
284,005,753

6,230,721

1,422,544

23,605,123

Ellen M. Hancock
281,886,912

8,325,288

1,446,818

23,605,123

Richard J. Harrington
288,832,345

1,412,721

1,413,952

23,605,123

Edward J. Ludwig
286,647,377

3,609,756

1,401,885

23,605,123

Joseph P. Newhouse
283,780,193

6,480,826

1,397,999

23,605,123

 
 
 
 
 






2. The proposal to approve the appointment of KPMG LLP as the Company's and its subsidiaries' independent registered public accounting firm for 2014 was approved based on the following votes:
Votes For

Votes Against

Abstentions

Broker Non-Votes
310,788,331

3,258,097

1,217,713

None

3. The proposal to approve amendments to the Company's Articles of Incorporation and By-Laws to eliminate supermajority voting provisions was approved based on the following votes:
Votes For

Votes Against

Abstentions

Broker Non-Votes

289,104,712

1,209,953

1,344,353

23,605,123


4. The proposal to approve an amendment to the Company's Articles of Incorporation to provide holders of at least twenty-five percent of the voting power of all outstanding shares the right to call a special meeting of shareholders was approved based on the following votes:
Votes For

Votes Against

Abstentions

Broker Non-Votes

289,321,065

1,050,576

1,287,377

23,605,123


5. The proposal to approve the proposed amendment to the Amended Aetna Inc. 2010 Stock Incentive Plan to increase the number of shares authorized to be issued under the Plan was approved based on the following votes:
Votes For

Votes Against

Abstentions

Broker Non-Votes

254,235,579

35,882,210

1,541,229

23,605,123


6. The proposal to approve the Company's executive compensation on a non-binding advisory basis was approved based on the following votes:
Votes For

Votes Against

Abstentions

Broker Non-Votes

254,877,575

33,396,945

3,384,498

23,605,123


7A. A shareholder proposal requesting that the Board adopt a policy that the Chair of the Board be an independent director was not approved based on the following votes:
Votes For

Votes Against

Abstentions

Broker Non-Votes

76,578,200

213,332,896

1,747,922

23,605,123


7B. A shareholder proposal requesting that the Board amend the Company's political contributions policy to expand Board oversight over the Company's political expenditures was not approved based on the following votes:
Votes For

Votes Against

Abstentions

Broker Non-Votes

14,441,793

258,861,256

18,355,969

23,605,123


7C. A shareholder proposal requesting that the Board amend the Company's political contributions policy to provide that the Company will disclose annually all payments it made in the previous calendar year to tax-exempt organizations (other than charitable organizations not permitted to engage in lobbying as a substantial part of their activities) that were used, or that the Company has reasonable grounds to believe were used, for a political purpose was not approved based on the following votes:
Votes For

Votes Against

Abstentions

Broker Non-Votes

72,408,831

194,199,119

25,051,068

23,605,123








Section 9 - Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

3.1    Amended and Restated Articles of Incorporation of Aetna Inc. effective May 30, 2014
3.2    Amended and Restated By-Laws of Aetna Inc. effective May 30, 2014
99.1     Amended Aetna Inc. 2010 Stock Incentive Plan, as amended May 30, 2014 *

* Compensatory plan or arrangement.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
Aetna Inc.

Date: June 4, 2014
By:
/s/ Rajan Parmeswar
 
 
Name: Rajan Parmeswar
 
 
Title: Vice President, Controller and Chief Accounting Officer






Exhibit
Number
Description
 
 
3.1
Amended and Restated Articles of Incorporation of Aetna Inc. effective May 30, 2014
3.2
Amended and Restated By-Laws of Aetna Inc. effective May 30, 2014
99.1
Amended Aetna Inc. 2010 Stock Incentive Plan, as amended May 30, 2014 *    

* Compensatory plan or arrangement.